Axcelis Technologies filings document the formal disclosures of a semiconductor equipment company focused on ion implantation systems and lifecycle support. Its Form 8-K reports cover operating results, material events, financial-condition updates, executive officer changes and annual-meeting voting results.
Proxy materials describe board elections, stockholder voting mechanics, independent auditor ratification, executive compensation and share ownership by directors, officers and significant holders. The filing record also includes disclosures related to material agreements, governance matters and capital-structure subjects tied to the company’s common stock and public-company reporting obligations.
Axcelis Technologies director Jorge Titinger sold 1,000 shares of common stock in an open-market transaction at $80.00 per share on February 20, 2026. After this sale, he directly held 6,477 shares, including 3,586 shares issuable upon vesting of restricted stock units granted under the 2012 Equity Incentive Plan that remain subject to forfeiture.
Jorge Titinger reported a sale of 2,000 common shares. The sale is shown as executed on 12/17/2025 for $172,100. The filing also lists restricted stock vesting events of 115 shares on 08/15/2022 and 885 shares on 05/25/2025.
Axcelis Technologies reported lower results for the fourth quarter and full year 2025 while highlighting strong aftermarket performance and progress on its pending merger with Veeco. Full-year revenue was $839.0 million, down from $1,017.9 million in 2024, with GAAP diluted EPS falling from $6.15 to $3.80. Fourth-quarter revenue declined to $238.3 million from $252.4 million, and GAAP diluted EPS slipped to $1.10 from $1.54. Management emphasized record CS&I (aftermarket) revenue, expanded gross margins, and more than $100 million of free cash flow for 2025, alongside returning over $120 million to shareholders. For Q1 2026, the company guides to revenue of about $195 million, GAAP EPS of roughly $0.38, and non-GAAP EPS of about $0.71, reflecting ongoing transaction and integration costs related to the planned Veeco merger.
Reinhart Partners has disclosed a significant ownership stake in Axcelis Technologies Inc. common stock. The firm reports beneficial ownership of 1,589,898 shares, representing 5.18% of the outstanding common shares as of 12/31/2025.
Reinhart holds sole voting power over 1,457,777 shares and sole dispositive power over 1,589,898 shares, with no shared voting or dispositive authority. The firm certifies these securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Axcelis.
Axcelis Technologies reported that its stockholders overwhelmingly approved key proposals related to the company’s pending merger with Veeco Instruments. At a special meeting, 25,228,112 shares, or about 82.18% of eligible voting power, were represented, establishing a quorum.
Stockholders approved the share issuance needed to complete the merger, with 24,128,309 votes (95.84%) in favor and 1,048,205 (4.16%) against, and also approved a potential adjournment proposal, though it was not needed. The merger still requires remaining regulatory approvals, including from China’s State Administration for Market Regulation, and is expected to close in the second half of 2026.
Axcelis Technologies reported that its stockholders approved key proposals related to the company’s pending merger with Veeco Instruments at a special meeting on February 6, 2026. Shareholders backed the issuance of Axcelis common stock required under the merger agreement, with 24,128,309 votes, or 95.84% of votes cast, in favor and 1,048,205 against. A related proposal to adjourn the meeting if more votes were needed also passed, with 92.86% support, but was not required. The meeting had strong participation, with 25,228,112 shares present in person or by proxy out of 30,699,201 shares outstanding as of the record date. Completion of the merger remains subject to customary closing conditions, including final approval from China’s State Administration for Market Regulation, and Axcelis and Veeco continue to expect closing in the second half of 2026.
Axcelis Technologies filed an update on its planned merger with Veeco Instruments, outlining progress on regulatory clearances and closing conditions. The United Kingdom Investment Security Unit issued a no further action letter on January 22, 2026, removing one regulatory hurdle.
Axcelis and Veeco determined that filings under Sweden’s Investment Screening Law are not required and subsequently waived the related closing condition. They are still working toward final approval from China’s State Administration for Market Regulation. The merger also depends on customary conditions, including Axcelis and Veeco stockholder approvals at special meetings scheduled for February 6, 2026, and both ISS and Glass Lewis have recommended voting FOR. The companies continue to expect completion in the second half of 2026.
Axcelis Technologies, Inc. provides an update on regulatory and shareholder approval progress for its pending merger with Veeco Instruments Inc. Axcelis reports that the U.K. Investment Security Unit issued a “no further action” letter for the merger, removing one regulatory hurdle. The companies also determined that filings are not required under Sweden’s Investment Screening Law and subsequently waived the related closing condition.
The merger still depends on remaining conditions, including final regulatory approval from China’s State Administration for Market Regulation and stockholder approvals at both companies. Special meetings for Axcelis and Veeco stockholders are scheduled for February 6, 2026, and proxy advisory firms Institutional Shareholder Services and Glass Lewis have recommended that stockholders vote in favor of the deal. Axcelis and Veeco continue to state that they expect the merger to close in the second half of 2026.
Axcelis Technologies filed an 8-K supplementing its Definitive Proxy Statement for the proposed merger with Veeco and announced it will hold a special meeting of stockholders on February 6, 2026 at 11:00 a.m. ET.
The filing discloses three stockholder lawsuits and fifteen demand letters challenging proxy disclosures, including a motion for a preliminary injunction filed on January 25, 2026. Axcelis says it denies the allegations but will voluntarily supplement the Definitive Proxy Statement to avoid delay or disruption to the Merger.
The supplement adds background, financial advisor analyses and assumptions, selected valuation ranges (Veeco implied equity per share of $30.14 to $36.54; Axcelis implied equity per share of $91.91 to $109.93; combined implied Veeco per-share range of $32.91 to $40.07), and advisor fee disclosures (UBS estimated fee ~$28.5 million).